Practice patterns and outcomes associated with intravenous albumin in patients with cirrhosis and acute kidney injury.
Kavish R. Patidar,Mohammad Adibuzzaman,Mobasshir Arshed Naved,Dylan Rodriquez,James E. Slaven,Ananth Grama,Archita P. Desai,Eduardo Vilar Gomez,Marwan Ghabril,Lauren Nephew,Niharika Samala,Melissa Anderson,Naga Chalasani,Eric S. Orman +13 more
TLDR
In this article, the impact of albumin use on patient outcomes remains unclear, however, guidelines recommend albumin as the plasma-expander of choice for acute kidney injury (AKI) in cirrhosis.Abstract:
Background & aims Guidelines recommend albumin as the plasma-expander of choice for acute kidney injury (AKI) in cirrhosis. However, the impact of these recommendations on patient outcomes remains unclear. We aimed to determine the practice-patterns and outcomes associated with albumin use in a large, nationwide-US cohort of hospitalized cirrhotics with AKI. Methods A retrospective cohort study was performed in hospitalized cirrhotics with AKI using Cerner-Health-Facts database from January 2009 to March 2018. 6786 were included for analysis on albumin-practice-patterns, and 4126 had available outcomes data. Propensity-score-adjusted model was used to determine the association between albumin use, AKI-recovery and in-hospital survival. Results Median age was 61-years (60% male, 70% white), median serum-creatinine was 1.8 mg/dL and median Model for End-stage Liver Disease Sodium (MELD-Na) score was 24. Albumin was given to 35% of patients, of which 50% received albumin within 48-hours of AKI-onset, and 17% received appropriate weight-based dosing. Albumin was used more frequently in patients with advanced complications of cirrhosis, higher MELD-Na scores and patients admitted to urban-teaching hospitals. After propensity-matching and multivariable adjustment, albumin use was not associated with AKI-recovery (odds ratio [OR] 0.70, 95% confidence-interval [CI]: 0.59-1.07, P = .130) or in-hospital survival (OR 0.76 [95% CI: 0.46-1.25], P = .280), compared with crystalloids. Findings were unchanged in subgroup analyses of patients with varying cirrhosis complications and disease severity. Conclusions USA hospitalized patients with cirrhosis and AKI frequently do not receive intravenous albumin, and albumin use was not associated with improved clinical outcomes. Prospective randomised trials are direly needed to evaluate the impact of albumin in cirrhotics with AKI.read more
Citations
More filters
Journal ArticleDOI
Albumin versus crystalloids for AKI in the cirrhotic patient
TL;DR: Spencer et al. as discussed by the authors proposed a method to detect the presence of brain tumor in the brain of a patient at the University of Colorado (University Hospital) Program (Founding), Aurora, Colorado.
Journal ArticleDOI
Albumin for AKI in cirrhosis - sham therapy or effective?
TL;DR: Patidar et al. as mentioned in this paper studied the outcomes associated with intravenous (IV) albumin in patients with cirrhosis and acute kidney injury (AKI), and reported that albumin use was not associated with AKI-recovery or in-hospital survival compared to crystalloids.
References
More filters
Journal ArticleDOI
Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms.
Alessia Bortoluzzi,Giulio Ceolotto,Elisabetta Gola,Antonietta Sticca,Sergio Bova,Filippo Morando,Salvatore Piano,Silvano Fasolato,S. Rosi,Angelo Gatta,Paolo Angeli +10 more
TL;DR: Albumin exerts a positive cardiac inotropic effect in rats with cirrhosis and ascites counteracting the negative effects of oxidative stress‐ and TNF‐α‐induced activation of NF‐κB‐iNOS pathway and oxidative Stress‐induced alteration of β‐receptor signaling.
Journal ArticleDOI
A comparison of a multistate inpatient EHR database to the HCUP Nationwide Inpatient Sample
TL;DR: Differences that were found are consistent across diagnosis and procedures categories and were specific to the psychiatric–behavioral and obstetrics–gynecology services areas.
Journal ArticleDOI
Neutrophil Gelatinase‐Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study
P. Huelin,Elsa Solà,Chiara Elia,Cristina Solé,A. Risso,Rebeca Moreira,Marta Carol,Núria Fabrellas,Octavi Bassegoda,Adrià Juanola,Gloria de Prada,Sonia Albertos,Salvatore Piano,Isabel Graupera,Xavier Ariza,Laura Napoleone,Elisa Pose,Xavier Filella,Manuel Morales-Ruiz,José Ríos,Javier Fernández,Wladimiro Jiménez,Esteban Poch,Ferran Torres,Pere Ginès +24 more
TL;DR: Urinary NGAL measured at day 3 had the greatest accuracy for differential diagnosis between ATN and other types of AKI, and NGAL was also an independent predictive factor of 28‐day mortality together with Model for End‐Stage Liver Disease score.
Journal ArticleDOI
Nationwide Increase in Hospitalizations and Hepatitis C Among Inpatients With Cirrhosis and Sequelae of Portal Hypertension
TL;DR: A significant increase in the incidence of hospitalization for complicated portal hypertension between 1998 and 2003 and a growing burden of hepatitis C-related disease have profound economic impact and underscore the need for interventions to prevent progression to advanced liver disease.
Journal ArticleDOI
Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study.
Lauren Lapointe-Shaw,Firass Georgie,David Carlone,Orlando Cerocchi,Hannah Chung,Yvonne DeWit,Jordan J. Feld,Jordan J. Feld,Laura Holder,Jeffrey C. Kwong,Beate Sander,Jennifer A. Flemming +11 more
TL;DR: These sensitive and specific algorithms can be used to define patient cohorts or detect clinical outcomes using health administrative data and will facilitate research into the adequacy of screening and treatment for patients with chronic viral hepatitis or other liver diseases.
Related Papers (5)
The impact of transient and persistent acute kidney injury on short-term outcomes in very elderly patients.
Incidence and Outcome of Sub-clinical Acute Kidney Injury Using penKid in Critically Ill Patients
François Dépret,Alexa Hollinger,Alexa Hollinger,Alain Cariou,Nicolas Deye,Antoine Vieillard-Baron,Marie-Céline Fournier,Samir Jaber,Charles Damoisel,Qin Lu,Xavier Monnet,Isabelle Rennuit,Michael Darmon,Marc Leone,Bertrand Guidet,Romain Sonneville,Philippe Montravers,Sebastien Pili-Floury,Jean-Yves Lefrant,Jacques Duranteau,Pierre-François Laterre,Nicolas Bréchot,Haikel Oueslati,Bernard Cholley,Joachim Struck,Oliver Hartmann,Alexandre Mebazaa,Etienne Gayat,Matthieu Legrand +28 more